دورية أكاديمية
أعرض في EDS

Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention.

التفاصيل البيبلوغرافية
العنوان: Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention.
المؤلفون: Frank MG, Weaver G, Raabe V
مؤلفون مشاركون: State of the Clinical Science Working Group of the National Emerging Pathogens Training, Education Center’s Special Pathogens Research Network2, State of the Clinical Science Working Group of the National Emerging Pathogens Training Education Center’s Special Pathogens Research Network
المصدر: Emerging infectious diseases [Emerg Infect Dis] 2024 May; Vol. 30 (5), pp. 854-863.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Atlanta, GA : National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), [1995-
مواضيع طبية MeSH: Hemorrhagic Fever, Crimean*/epidemiology , Hemorrhagic Fever, Crimean*/prevention & control , Hemorrhagic Fever, Crimean*/transmission , Hemorrhagic Fever, Crimean*/diagnosis , Hemorrhagic Fever, Crimean*/virology , Hemorrhagic Fever Virus, Crimean-Congo*/genetics, Humans ; Animals ; Ticks/virology
مستخلص: Crimean-Congo hemorrhagic fever (CCHF) is a tickborne infection that can range from asymptomatic to fatal and has been described in >30 countries. Early identification and isolation of patients with suspected or confirmed CCHF and the use of appropriate prevention and control measures are essential for preventing human-to-human transmission. Here, we provide an overview of the epidemiology, clinical features, and prevention and control of CCHF. CCHF poses a continued public health threat given its wide geographic distribution, potential to spread to new regions, propensity for genetic variability, and potential for severe and fatal illness, in addition to the limited medical countermeasures for prophylaxis and treatment. A high index of suspicion, comprehensive travel and epidemiologic history, and clinical evaluation are essential for prompt diagnosis. Infection control measures can be effective in reducing the risk for transmission but require correct and consistent application.
References: Int J Infect Dis. 2017 May;58:58-64. (PMID: 28249811)
Microorganisms. 2021 Sep 09;9(9):. (PMID: 34576803)
PLoS Negl Trop Dis. 2021 Apr 22;15(4):e0009299. (PMID: 33886556)
J Med Virol. 2021 Jan;93(1):182-183. (PMID: 32644233)
N Engl J Med. 2017 Jul 13;377(2):106-108. (PMID: 28700846)
Int J Infect Dis. 2017 May;58:82-89. (PMID: 28259724)
J Hosp Infect. 2020 May;105(1):43-52. (PMID: 31821852)
Emerg Infect Dis. 2023 Feb;29(2):268-277. (PMID: 36692327)
Antiviral Res. 2013 Oct;100(1):159-89. (PMID: 23906741)
Int J Infect Dis. 2016 Apr;45:109-11. (PMID: 26972040)
Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):325-30. (PMID: 25213721)
Clin Infect Dis. 2007 Oct 1;45(7):e96-100. (PMID: 17806044)
Jpn J Infect Dis. 2012;65(5):392-5. (PMID: 22996211)
Emerg Infect Dis. 2019 Feb;25(2):321-324. (PMID: 30666932)
Int J Infect Dis. 2008 Jul;12(4):374-9. (PMID: 18063402)
Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S794-800. (PMID: 2749111)
Emerg Infect Dis. 2023 Feb;29(2):252-259. (PMID: 36692301)
Zoonoses Public Health. 2018 Aug;65(5):465-480. (PMID: 29676526)
Viruses. 2019 Jun 28;11(7):. (PMID: 31261754)
Emerg Infect Dis. 2024 May;30(5):847-853. (PMID: 38666566)
Pathog Glob Health. 2022 May;116(3):193-200. (PMID: 34866547)
Curr Mol Med. 2005 Dec;5(8):753-60. (PMID: 16375710)
J Infect Dis. 2017 Dec 12;216(11):1386-1397. (PMID: 28482001)
Int J Infect Dis. 2009 May;13(3):369-73. (PMID: 18980852)
J Clin Apher. 2021 Oct;36(5):780-784. (PMID: 34061376)
F1000Res. 2018 Oct 29;7:. (PMID: 30416710)
Jpn J Infect Dis. 2004 Apr;57(2):55-7. (PMID: 15118210)
Clin Vaccine Immunol. 2010 Jul;17(7):1086-93. (PMID: 20484568)
Clin Microbiol Infect. 2006 Jun;12(6):551-4. (PMID: 16700704)
Antiviral Res. 2022 Mar;199:105244. (PMID: 35026307)
Nat Rev Microbiol. 2023 Jul;21(7):463-477. (PMID: 36918725)
Parasitology. 2004;129 Suppl:S177-89. (PMID: 15938511)
Int J Infect Dis. 2015 Apr;33:120-2. (PMID: 25576827)
J Med Entomol. 1979 May 22;15(4):307-417. (PMID: 113533)
J Clin Virol. 2012 Feb;53(2):159-61. (PMID: 22079303)
BMC Pediatr. 2020 Jun 9;20(1):288. (PMID: 32517812)
Agri. 2018 Jan;30(1):12-17. (PMID: 29450871)
Vector Borne Zoonotic Dis. 2015 Sep;15(9):565-7. (PMID: 26347941)
Vet Sci. 2022 Aug 29;9(9):. (PMID: 36136678)
Vector Borne Zoonotic Dis. 2014 Nov;14(11):827-9. (PMID: 25409276)
J Clin Virol. 2010 Aug;48(4):282-4. (PMID: 20598630)
Am J Trop Med Hyg. 1997 Nov;57(5):519-25. (PMID: 9392589)
Science. 2022 Jan 07;375(6576):104-109. (PMID: 34793197)
Emerg Infect Dis. 2007 Nov;13(11):1769-72. (PMID: 18217568)
J Clin Virol. 2010 Jul;48(3):184-6. (PMID: 20444644)
PLoS Negl Trop Dis. 2020 Jun 3;14(6):e0008364. (PMID: 32492018)
Emerg Infect Dis. 2024 May;30(5):864-873. (PMID: 38666553)
Eur Radiol. 2018 Sep;28(9):3893-3901. (PMID: 29532238)
فهرسة مساهمة: Investigator: RT Davey; NA Hynes; MG Kortepeter; N Bhadelia; K Dierberg; AK Mehta; CB Levine; PC Iwen; DA Bente; J Chan; A Beitscher
Keywords: Crimean-Congo hemorrhagic fever; bunyavirus; countermeasure; treatment; vaccine; vector-borne infections; viral hemorrhagic fever; viruses
تواريخ الأحداث: Date Created: 20240426 Date Completed: 20240426 Latest Revision: 20240502
رمز التحديث: 20240502
مُعرف محوري في PubMed: PMC11060446
DOI: 10.3201/eid3005.231647
PMID: 38666548
قاعدة البيانات: MEDLINE
الوصف
تدمد:1080-6059
DOI:10.3201/eid3005.231647